Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.97 -0.06 (-1.29%)
As of: Sep 29, 2026 · 3:50 PM EDT

Curanex Pharmaceuticals (CURX) Operating Leases (2025 - 2026)

Updated

Curanex Pharmaceuticals' Operating Leases came in at $181,948 for Q2 2026, compared with $5,816 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Operating Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals' Operating Leases was $224,010.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Curanex Pharmaceuticals 7.25 Mn -6.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181,948.00
Dec 31, 2025 224,010.00
Jun 30, 2025 5,816.00
API Access

Curanex Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CURX&period=max&api_key=YOUR_API_KEY